Patents by Inventor Andrew L. Gostine

Andrew L. Gostine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intravenous fluid
    Patent number: 10124021
    Abstract: Disclosed are intravenous hypertonic electrolyte solutions for treating intracranial hypertension while reducing the risk of inducing hyperchloremic metabolic acidosis. The solutions are characterized by a ratio of sodium-to-chloride (Na:Cl) ions of 1.2-1.6 and a total osmolarity of 310-400 mEq/L for a maintenance solution, and a total osmolarity greater than 1000 mEq/L for an initiation solution.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: November 13, 2018
    Inventor: Andrew L. Gostine
  • INTRAVENOUS FLUID
    Publication number: 20180177821
    Abstract: Disclosed are intravenous hypertonic electrolyte solutions for treating intracranial hypertension while reducing the risk of inducing hyperchloremic metabolic acidosis. The solutions are characterized by a ratio of sodium-to-chloride (Na:Cl) ions of 1.2-1.6 and a total osmolarity of 310-400 mEq/L for a maintenance solution, and a total osmolarity greater than 1000 mEq/L for an initiation solution.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 28, 2018
    Inventor: Andrew L. Gostine